| Astral Resources NL (AAR) ORDINARY FULLY PAID |
Materials |
$280 |
Theia Deeps Delivers Wide High-Grade Hits
|
13 Oct 2026 9:15AM |
$0.170 |
$0.155 |
fallen by
8.82%
|
|
AAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Astral Resources announced new drilling results from the Theia Deposit at the Mandilla Gold Project in Western Australia.
- Hole AMRCD377 returned 23m at 2.39g/t Au from 418m and 33m at 5.02g/t Au from 450m below the current Mineral Resource pit shell.
- AMRCD377 delivered an aggregated 143m at 1.87g/t Au from 418m across four mineralised intervals.
- The deeper high-grade results are considered supportive of potential future underground mining beneath the proposed Theia open pit.
- Hole AMRCD466, drilled about 150m south of the current resource, returned 42m at 0.89g/t Au from 285m and 6m at 13.2g/t Au from 595m.
- Hole AMRCD467 returned 11.2m at 5.82g/t Au from 220.19m, 7.5m at 4.00g/t Au from 257.7m, 13.7m at 1.70g/t Au from 282.3m and 35.9m at 1.57g/t Au from 303.1m.
- AMRCD466 and AMRCD467 confirmed southern extensions of south-west dipping Theia-style gold mineralisation.
- The Theia Deeps diamond drilling program had expanded to 21 holes for 11,000m, with 18 holes completed at the time of the announcement.
- RC in-fill drilling at the Theia Stage 1 open pit was continuing, with 28,350m completed of a planned 44,400m program.
- Astral stated that heritage survey approvals were advancing and future drilling was planned at Spargoville and Kamperman after Mandilla work.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$11 |
Travelan Phase 2 Study Results Published
|
13 Oct 2026 9:15AM |
$0.042 |
$0.034 |
fallen by
19.05%
|
|
| Develop Global Limited (DVP) ORDINARY FULLY PAID |
Materials |
$1,353 |
2026 Notice of Annual General Meeting
|
13 Oct 2026 9:14AM |
$4.330 |
$4.100 |
fallen by
5.31%
|
|
| Memphasys Limited (MEM) ORDINARY FULLY PAID |
Health Care |
$12 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
13 Oct 2026 9:14AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
MEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report and Appendix 4C covered the period ended 30 September 2026.
- Memphasys reported record invoiced revenue of A$211,000, up 41% from the June 2026 quarter.
- Customer cash receipts were a record A$183,000.
- New distribution agreements expanded European coverage into Poland, the Nordic markets, the Czech Republic, Slovakia and Kazakhstan.
- Regulatory approvals activated commercial sales in Vietnam, Thailand and Türkiye.
- Repeat orders were received from Italy, the UK and MENA.
- Dr Arne Schierau was appointed Director, Commercial Operations Europe.
- 10 new IVF clinics across Germany, Poland, Sweden, Finland and Denmark were trialling Felix™.
- Karolinska IVF in Sweden placed an initial Felix™ order after quarter end to begin clinical evaluation.
- Clinics trialling Felix™ were estimated to represent around 10,000 ART cycles annually.
- Commercial agreement minimum values disclosed included Poland about A$350,000, Nordic markets about A$869,000, Czech Republic/Slovakia/Kazakhstan about A$674,000, Vietnam A$530,000 and Thailand about A$430,500.
- Monash IVF expanded its Felix™ implementation trial to an additional clinic, with potential deployment across 22 clinics subject to successful implementation.
- The pivotal Felix™ study presented at FSANZ reported higher embryo utilisation than density gradient centrifugation, 58.8% versus 49.1%.
- Memphasys identified a potential FDA 510(k) pathway for Felix™, with Pre-Submission engagement planned and a formal submission targeted for Q1 CY2027 subject to feedback.
- Felix™ cartridge shelf life was extended from 18 months to 24 months.
- Memphasys announced a A$3.5 million funding agreement with Peters Investments to support commercial capability, manufacturing, inventory and market expansion.
- Melissa Peters was appointed a non-independent Non-Executive Director on 29 September 2026.
- Quarter-end cash and cash equivalents were A$3.458 million.
- Appendix 4C reported net cash used in operating activities of A$1.159 million.
- Appendix 4C reported net cash used in investing activities of A$1,000.
- Appendix 4C reported net cash from financing activities of A$3.441 million.
- Payments to related parties and associates totalled about A$70,000 for the quarter.
- Estimated funding available based on quarter-end cash was 2.98 quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aussie Broadband Limited (ABB) ORDINARY FULLY PAID |
Communication Services |
$1,241 |
Update - Notification of buy-back - ABB
|
13 Oct 2026 9:14AM |
$4.070 |
$4.060 |
fallen by
0.25%
|
|
| La Trobe Private Credit Fund (LF1) ORDINARY UNITS FULLY PAID |
Financials |
$254 |
Application for quotation of securities - LF1
|
13 Oct 2026 9:14AM |
$1.885 |
$1.885 |
fallen by
0%
|
|
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$94 |
LRT NAV Estimate - 9 October 2026
|
13 Oct 2026 9:13AM |
$1.900 |
$1.850 |
fallen by
2.63%
|
|
| Baby Bunting Group Limited (BBN) ORDINARY FULLY PAID |
Consumer Discretionary |
$143 |
2026 AGM Presentation
|
13 Oct 2026 9:13AM |
$1.020 |
$1.045 |
risen by
2.45%
|
|
BBN - Price-sensitive ASX Announcement
Full Release
Key Points
- The document is Baby Bunting Group Limited’s 2026 Annual General Meeting presentation dated 13 October 2026.
- FY26 total sales were $556.0 million, up 6.5% on the prior corresponding period, with comparable sales growth of 3.5%.
- Gross margin reached a record 41.2%, up 100 basis points versus the prior year, with second half margin at 41.4%.
- Pre-AASB 16 EBITDA was $37.6 million, representing 6.8% of sales, up 140 basis points year on year.
- Pro forma NPAT was $16.1 million, up 33.9%, while statutory NPAT was $11.2 million, up 17.5%.
- Net debt was $16.2 million, with debt headroom of more than $60 million and cash conversion of 96%.
- Baby Bunting completed 12 Store of the Future refurbishments in FY26, taking the total to 15 stores trading.
- Refurbished Store of the Future locations delivered average sales growth of 18% in FY26, increasing to 20% on a cumulative average basis in the FY27 trading update.
- Three large-format stores opened in Dubbo, Westgate NZ and Tuggerah, while Hornsby was exited and Bentleigh relocated to Mentone.
- Three Baby Bunting Junior small-format pilot stores were opened in Marion, Plenty Valley and Robina.
- BabyBuntingMedia contributed $5.8 million in revenue in its first full year.
- The company signed an exclusive three-year brand partnership with Stokke.
- In-store endless aisle was deployed across all stores and online delivery was scaled so stores fulfil 100% of deliveries.
- The growth plan focuses on growing market share, growing EBITDA and growing return on invested capital.
- Management sees a pathway to a long-term EBITDA margin above 10% on a pre-AASB 16 basis.
- The strategy targets gross margin above 43% over the medium term through mix, retail media and offshore consolidation.
- The business aims to expand its network from about 80 stores, targeting more than 120 large-format stores over time.
- FY27 targets are sales of $585 million to $600 million, comparable sales growth of 3% to 5%, gross margin of 42% and capex of $33 million to $37 million.
- FY27 pro forma NPAT is expected to be between $19.0 million and $21.0 million, assuming trading conditions remain broadly stable.
- As at 4 October 2026, underlying comparable store sales growth was 2.2% year to date, with Australia up 2.0% and New Zealand up 8.7% on a constant currency basis.
- The FY27 store rollout plan includes 10 to 12 refurbishments, three new large-format stores and the Kawana to Baringa relocation.
- Refurbishment costs reduced from an average of $1.7 million per store in 1H FY26 to $1.5 million in 2H FY26, with a target of $1.4 million for A and B grade stores and about $1.0 million for C and D grade stores.
- Refurbished stores maintained a capital payback period of less than three years.
- Pro forma adjustments primarily exclude employee equity incentive expenses, transformation project expenses and related tax impacts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bounty Oil & Gas NL (BUY) ORDINARY FULLY PAID |
Energy |
$12 |
LB-32 TECHNICAL DUE DILIGENCE PROGRAM COMMENCES
|
13 Oct 2026 9:13AM |
$0.007 |
$0.009 |
risen by
28.57%
|
|
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$105 |
BB1 to Present at Simons Foundation and ThinkEquity in NYC
|
13 Oct 2026 9:13AM |
$0.620 |
$0.595 |
fallen by
4.03%
|
|
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$84 |
Update - Notification of buy-back - BOL
|
13 Oct 2026 9:12AM |
$2.430 |
$2.310 |
fallen by
4.94%
|
|
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$12,650 |
Letter to Shareholders
|
13 Oct 2026 9:12AM |
$34.070 |
$37.610 |
risen by
10.39%
|
|
| Rumble Resources Limited (RTR) ORDINARY FULLY PAID |
Materials |
$62 |
Earaheedy Zinc project Update
|
13 Oct 2026 9:12AM |
$0.049 |
$0.047 |
fallen by
4.08%
|
|
RTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Earaheedy hosts a pit-constrained Inferred Mineral Resource of 94Mt at 3.1% Zn+Pb and 4.1g/t Ag at a 2% Zn+Pb cutoff.
- The resource contains 2.2Mt of zinc, 0.7Mt of lead and 12.6Moz of silver.
- Rumble describes Earaheedy as one of the largest zinc sulphide discoveries globally in the last decade.
- Chinook, Tonka and Navajoh remain open down dip and along strike, with less than 30% of the 70km mineralised unconformity effectively drill tested.
- The project is located about 110km northeast of Wiluna in Western Australia with access to major infrastructure.
- Metallurgical testwork on Chinook achieved 79% zinc recovery into a 61% Zn+Pb bulk concentrate.
- HydroFloat technology demonstrated the potential to reject over 30% of barren material early in processing.
- Testwork supports a simplified semi-autogenous milling and coarse grind flowsheet with potential capex and opex benefits.
- An internal 2025 scoping study assessed a 10Mtpa plant producing bulk Zn/Pb/Ag concentrate and assumed zero silver payability in bulk concentrate.
- Rumble is undertaking further work to assess separate zinc and lead/silver concentrates to improve metal payability and project economics.
- The zinc price had risen 35% over the previous 12 months to above US$4,000 per tonne, supporting a positive market outlook.
- Tight zinc, lead and bulk concentrate markets and negative treatment charges are seen as favourable for securing a strategic partner.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$36 |
Change in substantial holding
|
13 Oct 2026 9:12AM |
$0.690 |
$0.695 |
risen by
0.72%
|
|
| iTech Minerals Ltd (ITM) ORDINARY FULLY PAID |
Materials |
$10 |
Second Gold Shoot at Sabre Expanded
|
13 Oct 2026 9:12AM |
$0.046 |
$0.041 |
fallen by
10.87%
|
|
ITM - Price-sensitive ASX Announcement
Full Release
Key Points
- Final gold assays expanded Sabre Shoot 2 at the Reynolds Range Gold-Antimony Project in the Northern Territory.
- Updated Shoot 2 results included SBRC26-008 at 29m @ 2.36 g/t Au from 81m, extended from the previously reported 21m @ 2.04 g/t Au.
- SBRC26-010 returned 10m @ 2.17 g/t Au from 162m, replacing a previously reported 1m @ 5.77 g/t Au from 166m.
- SBRC26-011 returned a new intercept of 8m @ 0.83 g/t Au from 48m.
- SBRC26-009 remained unchanged at 8m @ 1.15 g/t Au from 113m.
- SBRC26-008 was mineralised over much of its length, with a broad downhole interval of 98m @ 1.06 g/t Au from 12m.
- Shoot 2 has been intersected in four iTech drill holes over about 110m vertical extent and remains open at depth.
- The strike extent of Shoot 2 has not yet been established and requires more drilling.
- iTech interprets Shoots 1 to 4 as higher-grade zones along a single controlling shear zone.
- The shear zone between Shoots 1 and 2 has only been tested to about 120m depth, leaving potential for additional mineralisation between and below the shoots.
- Shoot 1 has been drilled to about 270m below surface, compared with about 150m at Shoot 2.
- The Sabre mineralisation style is described as steeply dipping, structurally controlled gold-antimony mineralisation hosted in metasediments and associated with stibnite and sulphides.
- Metallurgical test work is underway to assess gold and antimony recoveries and possible future reporting of a gold equivalent.
- Deep diamond drilling is planned from mid-November to test Shoot 1 below 300m, with later phases targeting depths below 500m vertical.
- Follow-up drilling is also planned to test Shoot 2 below 150m and along strike, and to test the shear zone between and below the shoots.
- No Mineral Resource has been estimated at Sabre, and the potential for further mineralisation is currently conceptual.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Baby Bunting Group Limited (BBN) ORDINARY FULLY PAID |
Consumer Discretionary |
$143 |
2026 AGM addresses, proxy summary and trading update
|
13 Oct 2026 9:12AM |
$1.020 |
$1.045 |
risen by
2.45%
|
|
BBN - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement dated 13 October 2026 covering AGM addresses, proxy summary and trading update with FY27 guidance reaffirmed.
- FY27 year-to-date underlying comparable store sales growth was 2.2% as at 4 October 2026, including 2.0% in Australia and 8.7% in New Zealand on a constant currency basis.
- Sales moderation was attributed to seven store closures for refurbishment, with performance expected to normalise as stores reopen.
- Store of the Future cumulative average sales growth increased to 20% across 17 refurbished stores now trading.
- FY27 refurbishment program targets 10 to 12 stores, with 6 to be completed in the first half.
- Refurbishment risks identified were closure duration targeted at 10 to 12 weeks per store and the level of sales redirection to nearby stores.
- The store network stood at 80 stores, with three new large format stores committed for FY27 including Ballina opening in December and two in late Q4.
- Baby Bunting plans to relocate the Kawana store in Queensland to Baringa in December and continue refining its small format pilot stores.
- FY27 pro forma NPAT guidance was reaffirmed at $19.0 million to $21.0 million, with earnings expected to be weighted about one-third in the first half and two-thirds in the second half.
- FY27 guidance assumptions include total sales of $585 million to $600 million, comparable store sales growth of 3% to 5%, gross margin of 42% and capital expenditure of $33 million to $37 million funded through operating cash flow.
- FY26 results included record sales of $556.0 million, 6.5% growth, gross margin of 41.2% and pro forma NPAT of $16.1 million, up 33.9%.
- The Chair said Baby Bunting sees a long-term opportunity to expand to more than 120 stores across Australia and New Zealand.
- New Zealand was described as a key growth market, with FY26 comparable store sales growth of 17.0% and a target to reach pro forma NPAT break-even in the second half of FY27.
- The Board decided not to pay a FY26 dividend in order to prioritise investment in the store refurbishment program.
- Leadership updates included Richard Vincent joining the Board, Gary Levin retiring from the Board and CFO Darin Hoekman planning to step down after a successor is appointed.
- Proxy votes before the AGM showed strong support for all items, with more than 99% of votes cast for each resolution on director elections, remuneration report, CEO incentive grants and approval of the LTI Plan.
- The company said gross margin in FY27 was tracking to plan and it continued to monitor trading conditions given interest rate rises and cost-of-living pressures.
- The outlook assumes no significant changes in economic and retail trading conditions and no significant increases in sea and land freight expenses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OMG Group Limited (OMG) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Cleansing Notice
|
13 Oct 2026 9:11AM |
$0.007 |
$0.006 |
fallen by
14.29%
|
|
| Pilbara Gold Limited (PGL) ORDINARY FULLY PAID |
Materials |
$108 |
Roe Hills Mineralised Footprint Increases
|
13 Oct 2026 9:11AM |
$0.490 |
$0.460 |
fallen by
6.12%
|
|
PGL - Price-sensitive ASX Announcement
Full Release
Key Points
- Pilbara Gold reported additional high-grade gold drill results from the Terra Prospect at the Roe Hills Gold Project.
- The Terra bedrock gold mineralised footprint has increased to more than 1,500m of strike and remains open north, south and at depth.
- Hole 26RHRC016 returned 11m @ 3.63g/t Au from 104m including 6m @ 5.85g/t Au, plus 9m @ 2.24g/t Au from 144m including 2m @ 8.29g/t Au.
- Other significant results included 11m @ 1.04g/t Au in 26RHRC013, 10m @ 1.03g/t Au in 26RHRC018 and 1m @ 11.01g/t Au in 26RHRC014.
- Two separate mineralised zones were intersected in Terra South hole 26RHRC016, highlighting stacked mineralisation.
- PGL said strong continuity between drill fences supports the potential scale of a linear gold corridor associated with a major shear zone.
- Mineralisation is hosted in basaltic and ultramafic rocks with quartz-carbonate veining and pyrite-sericite alteration similar to major Eastern Goldfields systems.
- Phase 1 drilling was delayed by heavy rain and difficult cover conditions, with some holes abandoned, but completion at Terra and Caliburn was still targeted for October.
- Next steps were to complete Phase 1 drilling, finalise interpretation, undertake multi-element geochemical assessment and begin wireframing for Phase 2 targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| White Cliff Minerals Limited (WCN) ORDINARY FULLY PAID |
Materials |
$89 |
New Cu Discovery on 2.8km Structure Parallel to Danvers 1
|
13 Oct 2026 9:11AM |
$0.029 |
$0.026 |
fallen by
10.34%
|
|
WCN - Price-sensitive ASX Announcement
Full Release
Key Points
- White Cliff Minerals announced a new copper discovery on an untested parallel structure to Danvers 1 at the Rae Copper Project.
- Drillhole DAN26053 was the first hole into the new structure and intersected multiple zones of copper sulphides from as shallow as 16m downhole.
- The newly identified parallel structure is mapped for approximately 2.8km and lies less than 200m east of the Danvers 1 trend.
- DAN26053 recorded a total of 28.52m of observed copper sulphides in multiple zones of chalcocite and chalcopyrite-bearing veins and breccias.
- Copper sulphides were intersected in every recent north-east infill hole at Danvers 1, improving confidence in mineral continuity.
- DAN26051 returned 43.68m of visual copper sulphides.
- DAN26055 returned 165.67m of visual copper sulphides.
- DAN26057 returned 94.50m of visual copper sulphides.
- The recent drilling expanded the Danvers 1 mineralised footprint to more than 2.3km northeast of the 2025 drilling area.
- The results are being used to refine the geological model and support a maiden Exploration Target and Mineral Resource Estimate for Danvers 1.
- Several additional parallel magnetic features remain untested near Danvers.
- A high-resolution airborne magnetic, gravity and radiometric survey is underway across 72km of the Rae Group contact and the Thor and Rocket targets.
- Till sampling at Thor and Rocket is planned to help identify additional near-surface copper targets.
- The announcement notes that laboratory assays for the newly reported visual sulphide observations are expected in 6 to 8 weeks.
- The announcement was released on 13 October 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$183 |
Remplir Shows Excellent Early Prostatectomy Results
|
13 Oct 2026 9:11AM |
$0.670 |
$0.670 |
fallen by
0%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Orthocell reported excellent early functional recovery data for Remplir in a five-patient prostatectomy case series involving advanced prostate cancer patients.
- All patients required extensive tumour removal with nerve preservation feasible on only one side, making recovery of continence and erectile function more challenging.
- Remplir was successfully placed in all five robotic prostatectomy procedures with no technical difficulties or significant additional operating time.
- No Remplir-related complications were reported during surgery or across approximately 12 months of follow-up.
- Three patients achieved pad-free urinary continence by six months, and overall 80% showed encouraging continence outcomes.
- Among four patients with erectile function before surgery, three showed some return of erectile function by 12 months, including one with oral medication alone and two with second-line treatment.
- All five patients had undetectable PSA levels at the time of reporting.
- Orthocell plans a larger prospective clinical trial to generate stronger evidence for post-operative erectile function and urinary continence outcomes.
- Remplir is already approved in seven jurisdictions, including the United States, so no additional regulatory approvals are needed for use in prostatectomy in those markets.
- Orthocell said Remplir has now been used in more than 300 prostatectomy procedures in Australia.
- The company estimates the U.S. total addressable market for Remplir in nerve-sparing robotic-assisted radical prostatectomy could expand from US$1.6 billion to about US$2.0 billion.
- Orthocell stated it had A$44.1 million in available funds as at 30 June 2026 and no debt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,702 |
Appendix 3C
|
13 Oct 2026 9:10AM |
$46.090 |
$47.660 |
risen by
3.41%
|
|
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$12,650 |
Notice of Annual General Meeting/Proxy Form
|
13 Oct 2026 9:10AM |
$34.070 |
$37.610 |
risen by
10.39%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,702 |
Appendix 3C
|
13 Oct 2026 9:10AM |
$46.090 |
$47.660 |
risen by
3.41%
|
|
| Aoris International Fund (Class D) (Hedged) (Managed Fund) (DAOR) |
Financials |
$137 |
Monthly Performance Report September 2026
|
13 Oct 2026 9:10AM |
$1.910 |
$1.985 |
risen by
3.93%
|
|
| Aoris International Fund (Class B) (Unhedged) (Managed Fund) (BAOR) |
Financials |
$131 |
Monthly Performance Report September 2026
|
13 Oct 2026 9:09AM |
$2.340 |
$2.420 |
risen by
3.42%
|
|
Call 1300 880 160
Start a chat
Schedule a call
